Index S&P 500 P/E 17.22 EPS (ttm) 22.51 Insider Own 29.12% Shs Outstand 242.96M Perf Week 6.69%
Market Cap 93.24B Forward P/E 13.84 EPS next Y 28.00 Insider Trans -0.04% Shs Float 170.54M Perf Month 15.69%
Income 5.78B PEG 1.33 EPS next Q 6.24 Inst Own 65.65% Short Float 2.60% Perf Quarter 22.38%
Sales 71.58B P/S 1.30 EPS this Y 15.11% Inst Trans 4.09% Short Ratio 2.64 Perf Half Y 10.95%
Book/sh -14.48 P/B - EPS next Y 10.77% ROA 9.90% Short Interest 4.43M Perf Year 18.54%
Cash/sh 4.85 P/C 79.90 EPS next 5Y 12.92% ROE - 52W Range 289.98 - 417.14 Perf YTD 29.13%
Dividend Est. 2.92 (0.75%) P/FCF 18.84 EPS past 5Y 16.93% ROI 14.67% 52W High -7.09% Beta 1.50
Dividend TTM 2.70 (0.70%) Quick Ratio 1.06 Sales past 5Y 6.69% Gross Margin 15.15% 52W Low 33.66% ATR (14) 10.80
Dividend Ex-Date Jun 16, 2025 Current Ratio 1.19 EPS Y/Y TTM 11.60% Oper. Margin 15.15% RSI (14) 73.34 Volatility 3.44% 3.32%
Employees 316000 Debt/Eq - Sales Y/Y TTM 7.30% Profit Margin 8.07% Recom 2.03 Target Price 378.95
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q 8.73% Payout 12.00% Rel Volume 0.79 Prev Close 387.52
Sales Surprise 0.34% EPS Surprise 12.19% Sales Q/Q 5.66% Earnings Apr 25 BMO Avg Volume 1.68M Price 387.58
SMA20 9.60% SMA50 13.50% SMA200 11.38% Trades
Volume 1,147,719 Change 0.01%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-15-25 Downgrade Robert W. Baird
Outperform → Neutral
$336
Dec-17-24 Resumed JP Morgan
Neutral
$380
Nov-25-24 Downgrade Wells Fargo
Equal Weight → Underweight
$400 → $320
Nov-22-24 Downgrade Raymond James
Outperform → Mkt Perform
Oct-11-24 Initiated KeyBanc Capital Markets
Overweight
$475
Sep-03-24 Initiated Morgan Stanley
Equal-Weight
$427
May-30-24 Initiated Robert W. Baird
Outperform
$396
Mar-06-24 Initiated Barclays
Overweight
$356
Jan-04-24 Downgrade Bernstein
Outperform → Mkt Perform
$277 → $301
Dec-11-23 Downgrade Goldman
Buy → Neutral
$271
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$304
Apr-19-23 Resumed JP Morgan
Neutral
$257 → $283
Jul-06-22 Downgrade BMO Capital Markets
Market Perform → Underperform
$233 → $160
Jun-17-22 Initiated Loop Capital
Buy
$240
May-27-22 Upgrade Bernstein
Mkt Perform → Outperform
$273 → $271
Mar-29-22 Initiated Wells Fargo
Equal Weight
$267
Jan-10-22 Resumed Citigroup
Buy
$274 → $306
Dec-21-21 Downgrade JP Morgan
Overweight → Neutral
$270
Sep-27-21 Initiated SVB Leerink
Outperform
$320
Sep-24-21 Initiated UBS
Buy
$312
Show Previous Ratings
May-16-25 12:00PM
09:45AM
09:40AM
09:30AM
May-15-25 04:59PM
09:40AM
May-13-25 02:34PM
(Investor's Business Daily)
08:28AM
06:30AM
(The Wall Street Journal)
May-12-25 08:43AM
May-09-25 09:50AM
12:40AM
May-08-25 11:33AM
May-07-25 06:38PM
05:21AM
May-06-25 01:25PM
08:30AM
May-05-25 04:30PM
09:30AM
May-03-25 10:39PM
May-02-25 05:02PM
10:09AM
12:41AM
Apr-30-25 01:41PM
12:57PM
12:45PM
09:45AM
Apr-29-25 09:40AM
05:20AM
Apr-28-25 11:30AM
10:59AM
10:58AM
03:05AM
01:55AM
Apr-27-25 03:02AM
Apr-26-25 12:20PM
03:05AM
12:43AM
(Thomson Reuters StreetEvents)
Apr-25-25 01:42PM
12:14PM
12:07PM
09:30AM
08:40AM
07:53AM
07:51AM
07:49AM
07:39AM
(Associated Press Finance)
07:30AM
Apr-24-25 03:00AM
Apr-23-25 07:08PM
01:41PM
Apr-22-25 09:15AM
07:30AM
Apr-20-25 05:00AM
Apr-11-25 11:06AM
04:05AM
Apr-10-25 01:22PM
01:00PM
08:52AM
Apr-09-25 08:00AM
Apr-08-25 09:40AM
06:13AM
Apr-07-25 09:45AM
08:33AM
08:30AM
08:14AM
05:24AM
Apr-05-25 05:00AM
Apr-04-25 04:00PM
Apr-03-25 11:28PM
10:59PM
07:46AM
Apr-01-25 10:36AM
09:40AM
08:30AM
Mar-31-25 12:42PM
09:30AM
09:10AM
Mar-28-25 05:12AM
Mar-27-25 11:59AM
09:09AM
Mar-26-25 01:41PM
05:12AM
Mar-25-25 08:30AM
Mar-24-25 02:54PM
06:50AM
05:12AM
Mar-23-25 01:46PM
Mar-21-25 10:05AM
Mar-20-25 09:40AM
09:05AM
Mar-18-25 09:50AM
09:44AM
Mar-17-25 09:00AM
08:20AM
Mar-14-25 11:24AM
Mar-13-25 08:30AM
Mar-11-25 08:30AM
Mar-08-25 08:35AM
Mar-07-25 11:10AM
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Foster Jon M EVP and COO May 13 '25 Sale 369.32 15,698 5,797,661 12,646 May 15 05:54 PM Foster Jon M Officer May 13 '25 Proposed Sale 369.32 15,698 5,797,660 May 13 04:05 PM Berres Jennifer SVP & Chief Human Res. Officer Feb 14 '25 Sale 322.59 9,533 3,075,240 15,412 Feb 18 07:28 PM Berres Jennifer Officer Feb 14 '25 Proposed Sale 322.59 9,533 3,075,238 Feb 14 04:26 PM Berres Jennifer SVP & Chief Human Res. Officer Feb 07 '25 Option Exercise 115.12 11,780 1,356,151 30,511 Feb 11 06:16 PM Reiner Deborah M Former Officer Feb 11 '25 Proposed Sale 322.39 3,510 1,131,589 Feb 11 05:07 PM Whalen Kathleen M Former Officer Jan 31 '25 Proposed Sale 335.25 3,228 1,082,203 Jan 31 04:12 PM Whalen Kathleen M SVP & Chief Ethics Officer Nov 14 '24 Sale 357.99 1,474 527,677 9,454 Nov 18 05:50 PM Foster Jon M EVP and COO Nov 14 '24 Option Exercise 101.16 36,600 3,702,456 47,180 Nov 18 05:47 PM Billington Phillip G SVP-Internal Audit Services Nov 12 '24 Option Exercise 68.96 8,000 551,680 60,702 Nov 14 06:53 PM Billington Phillip G SVP-Internal Audit Services Nov 14 '24 Sale 350.00 3,897 1,363,950 52,702 Nov 14 06:53 PM Akdamar Erol R Group President Nov 12 '24 Option Exercise 68.96 20,000 1,379,200 20,000 Nov 14 06:50 PM Akdamar Erol R Group President Nov 14 '24 Sale 353.00 2,900 1,023,700 6,843 Nov 14 06:50 PM Whalen Kathleen M Officer Nov 14 '24 Proposed Sale 357.99 1,474 527,677 Nov 14 06:20 PM Akdamar Erol R Officer Nov 14 '24 Proposed Sale 357.86 4,872 1,743,480 Nov 14 06:19 PM Billington Phillip G Officer Nov 14 '24 Proposed Sale 350.00 3,897 1,363,950 Nov 14 06:17 PM Whalen Kathleen M SVP & Chief Ethics Officer Nov 11 '24 Option Exercise 173.12 4,710 815,395 14,164 Nov 13 06:17 PM Cuffe Michael S. EVP and Chief Clinical Officer Sep 10 '24 Option Exercise 145.24 22,080 3,206,899 51,758 Sep 12 05:21 PM Cuffe Michael S. EVP and Chief Clinical Officer Sep 12 '24 Sale 385.42 8,358 3,221,340 29,678 Sep 12 05:21 PM Cuffe Michael S. Officer Sep 12 '24 Proposed Sale 385.42 8,358 3,221,340 Sep 12 05:13 PM McManus Timothy M Group President Jul 31 '24 Option Exercise 77.13 7,500 578,475 30,927 Aug 02 05:21 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 29 '24 Option Exercise 145.24 8,280 1,202,587 19,598 Jul 31 05:44 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 31 '24 Sale 363.51 2,987 1,085,804 9,454 Jul 31 05:44 PM Whalen Kathleen M SVP & Chief Ethics Officer Jul 29 '24 Sale 359.92 1,864 670,891 12,441 Jul 31 05:44 PM Reiner Deborah M SVP - Mktg. & Communications Jul 29 '24 Sale 359.96 3,314 1,192,914 3,510 Jul 31 05:12 PM Whalen Kathleen M Officer Jul 31 '24 Proposed Sale 363.51 2,987 1,085,804 Jul 31 04:15 PM Wyatt Christopher F. SVP & Controller Jul 25 '24 Option Exercise 101.16 9,300 940,788 49,727 Jul 29 05:25 PM Wyatt Christopher F. SVP & Controller Jul 29 '24 Sale 360.20 4,000 1,440,782 40,449 Jul 29 05:25 PM Torres Kathryn A. SVP-Payer Contracting & Align. Jul 25 '24 Sale 355.05 1,857 659,328 17,755 Jul 29 05:18 PM Wyatt Christopher F. Officer Jul 29 '24 Proposed Sale 360.20 4,000 1,440,783 Jul 29 04:24 PM Reiner Deborah M Officer Jul 29 '24 Proposed Sale 359.96 3,314 1,192,914 Jul 29 04:18 PM Whalen Kathleen M Officer Jul 29 '24 Proposed Sale 359.92 1,864 670,891 Jul 29 04:07 PM
